by Editor | Nov 17, 2024 | Abortion, News, Vaccines
The FDA announced approval of a new RSV mRNA vaccine on October 23, 2024. This vaccine was developed and tested in a collaborative effort between ModernaTX and Merck and is intended for administration to adults 60 years of age or older. The press release announcing...
by Editor | Sep 21, 2023 | Abortion, Fetal & Vaccine Research, Vaccines
Two RSV (Respiratory Syncytial Virus) vaccines have been approved in 2023 – Arexvy (GSK) and Abrysvo (Pfizer). Arexvy is recommended for adults over 60 years of age and Abrysvo has also been recommended for administration to expectant mothers between 32 and 36...
God bless you both and your growing family! Your work has been appreciated beyond words. I look forward to your…
Science and medicine proclaim to want to save lives with sick innovation and research like we just read about but…
Want information to be in English
Dear GOD! Have mercy on this. Makes me want to vomit.